Showing results (251-260 of 367) with videos related to
Sort By:
Pageof 37
Cellular and Molecular Life Sciences : CMLS|September 12, 2006
Bioterrorism: management of major biological agentsP Bossi, D Garin, A Guihot, et al.The Journal of Rheumatology|December 1, 1994
T lymphocyte subsets in primary antiphospholipid syndromeT Papo, J C Piette, E Legac, et al.The British Journal of Dermatology|October 9, 1998
Epidermodysplasia verruciformis-like eruption complicating human immunodeficiency virus infectionC Barzegar, C Paul, P Saiag, et al.Blood|June 25, 1998
Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individualsJ E Schmitz, M A Forman, M A Lifton, et al.Journal of Virology|April 3, 1998
Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1D C Montefiori, K A Reimann, M S Wyand, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1990
Studies of cloned simian immunodeficiency virus-specific T lymphocytes. gag-specific cytotoxic T lymphocytes exhibit a restricted epitope specificityH Yamamoto, M D Miller, H Tsubota, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1986
Lymphoproliferative syndrome in an immunodeficient rhesus monkey naturally infected with an HTLV-III-like virus (STLV-III)L V Chalifoux, N W King, M D Daniel, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1995
CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 NefF Hadida, G Haas, N Zimmermann, et al.American Journal of Respiratory and Critical Care Medicine|October 1, 1994
Late CD8+ lymphocytic alveolitis after allogeneic bone marrow transplantation and chronic graft-versus-host diseaseV Leblond, H Zouabi, L Sutton, et al.AIDS (London, England)|July 9, 1999
HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study GroupA U Neumann, R Tubiana, V Calvez, et al.Pageof 37